Prignano F - Search Results

1

Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience.

Guerra P, Di Cesare A, Rosi E, Scandagli I, Silvi G, Nunziati G, Prignano F. Guerra P, et al. Among authors: prignano f. Life (Basel). 2024 Mar 16;14(3):395. doi: 10.3390/life14030395. Life (Basel). 2024. PMID: 38541719 Free PMC article.

2

Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.

Gisondi P, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, Girolomoni G, Naldi L; Psocare Study Group. Gisondi P, et al. J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e30-41. doi: 10.1111/j.1468-3083.2012.04450.x. Epub 2012 Feb 7. J Eur Acad Dermatol Venereol. 2013. PMID: 22313340

3

Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.

Ricceri F, Pescitelli L, Lazzeri L, Di Cesare A, Prignano F. Ricceri F, et al. Among authors: prignano f. J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e486. doi: 10.1111/jdv.14300. Epub 2017 May 15. J Eur Acad Dermatol Venereol. 2017. PMID: 28449189 No abstract available.

4

Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment.

Maglie R, Di Cesare A, Lazzeri L, Pescitelli L, Ricceri F, Vannucchi M, Massi D, Prignano F. Maglie R, et al. Among authors: prignano f. Br J Dermatol. 2018 Jan;178(1):303-304. doi: 10.1111/bjd.16003. Epub 2017 Dec 29. Br J Dermatol. 2018. PMID: 28940185 No abstract available.

5

Cutaneous hyperpigmentation induced by apremilast.

Di Cesare A, Pescitelli L, Ricceri F, Lazzeri L, Prignano F. Di Cesare A, et al. Among authors: prignano f. Int J Dermatol. 2018 Apr;57(4):473-474. doi: 10.1111/ijd.13831. Epub 2018 Jan 19. Int J Dermatol. 2018. PMID: 29350406 No abstract available.

6

Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines.

Cozzani E, Marzano AV, Caproni M, Feliciani C, Calzavara-Pinton P; Cutaneous Immunology group of SIDeMaST. Cozzani E, et al. G Ital Dermatol Venereol. 2018 Jun;153(3):305-315. doi: 10.23736/S0392-0488.18.06006-6. Epub 2018 Mar 30. G Ital Dermatol Venereol. 2018. PMID: 29600832 Free article.

7

Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis.

Pescitelli L, Lazzeri L, Tripo L, Ricceri F, Di Cesare A, Prignano F. Pescitelli L, et al. Among authors: prignano f. Dermatol Ther. 2018 Jul;31(4):e12614. doi: 10.1111/dth.12614. Epub 2018 Apr 30. Dermatol Ther. 2018. PMID: 29708289

8

Italian Guidelines in Pemphigus - adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV).

Feliciani C, Cozzani E, Marzano AV, Caproni M, Di Zenzo G, Calzavara-Pinton P; "Cutaneous Immunology" group of SIDeMaST. Feliciani C, et al. G Ital Dermatol Venereol. 2018 Oct;153(5):599-608. doi: 10.23736/S0392-0488.18.06073-X. Epub 2018 May 31. G Ital Dermatol Venereol. 2018. PMID: 29860771 Free article.

9

First case of secukinumab successful therapy in a very elderly psoriatic patient.

Ricceri F, Pescitelli L, Lazzeri L, Di Cesare A, Prignano F. Ricceri F, et al. Among authors: prignano f. Dermatol Ther. 2018 Sep;31(5):e12668. doi: 10.1111/dth.12668. Epub 2018 Sep 13. Dermatol Ther. 2018. PMID: 30209856 No abstract available.

10

Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.

Rosi E, Pescitelli L, Ricceri F, Di Cesare A, Novelli A, Pimpinelli N, Prignano F. Rosi E, et al. Among authors: prignano f. Dermatol Ther. 2019 Mar;32(2):e12792. doi: 10.1111/dth.12792. Epub 2018 Dec 21. Dermatol Ther. 2019. PMID: 30515931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page